Prostate Cancer Genetic Risk Evaluation and Screening Study (PROGRESS) identifier:
NCT05129605 (

People at high risk for prostate cancer due to an inherited mutation

Study Contact Information:

For additional information, please contact:

Olympia Price by phone: 857-238-3838
or by email: [email protected]  

About the Study

This study will look at how enhanced prostate cancer screening using MRI will improve early detection rates and further understanding of how inherited mutations can lead to development of prostate cancer.

What the Study Involves

Two groups of patients will be enrolled in this study:  

Both study groups will receive the same cancer screening tests:

Study participants will be followed for up to 20 years.

Study Location


This Study is Open To:

Men age 35-74 years old who meet the following criteria may be eligible:

This Study is Not Open To:

Men are not eligible to participate if they:


FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.